uMedical
Medicines
Substances
Companies
Statistics
Menu
All medicines
Raxone
Application withdrawn
Human
Orphan medicine
Details
EMA number
EMEA/H/C/002425
ATC code
N06BX13
Authorisation
-
Revision
-
EMA page
Therapeutic indication
Treatment of Lebers Hereditary Optic Neuropathy
MeSH:
Eye Diseases
Active substances
idebenone
Marketing Authorisation Holder
Chiesi Farmaceutici S.p.A.
MAH
Santhera Pharmaceuticals (Deutschland) GmbH
MAH
Timeline
Filter by authority:
EMA
Raxone authorised
8 Sept 2015
authorised
regulatory
Status changed: Authorised → Application withdrawn
6 Aug 2013
status_changed
regulatory
Raxone | uMedical